This is a community-generated profile. If you would like to claim it, please .
CRISPR Therapeutics Funding
$0
55 rounds
CRISPR Therapeutics has secured funding across 5 rounds and is valued at $0. Their most recent funding was raised on October 29, 2016.
Funding Rounds
IPO
Undisclosed amountB
$38000000
U
$64000000
A
$89000000A
$25000000Investors of CRISPR Therapeutics
Stephen M. Walker II
Founder @Unfair @Innovat Labs • Previously Product Leadership @Freeletics @Amazon @CapitalOne.16 years experience building products and product teams.
Brianna Buch
Adept technology project manager with four years of experience working in software technology industry.
Rounds
B
U
A
Jackson R. Martin
Co-Founder @NeumaNutriceuticals, previously worked for 3M company, looking for opportunities in the Los Angeles area
GSK (GlaxoSmithKline)
Vertex Pharmaceuticals
creates new possibilities in medicine to cure diseases and improve
Celgene
Franklin Templeton Investments
Delivering Exceptional Asset Management
Versant Ventures
Rounds
A
A